OTX2 is a homeodomain-containing transcription factor encoded by the OTX2 gene. It regulates gene networks critical for:
OTX2 antibodies enable detection and functional studies of this protein across experimental models.
The table below summarizes commercially available OTX2 antibodies and their specifications:
Eye and Brain Development: OTX2 is critical for optic nerve formation and midbrain-hindbrain boundary specification. Antibodies like AF1979 localize OTX2 in mouse embryonic nervous systems .
Retinal Maturation: OTX2 cooperates with Crx to regulate photoreceptor genes (e.g., rho, Pde6b). Knockdown studies using OTX2 antibodies revealed apoptosis in bipolar cells .
Medulloblastoma:
Sample Preparation: Heat-mediated antigen retrieval using citrate buffer (pH 6.0) .
Antibody Dilution:
Lysate Preparation: IMR-32 neuroblastoma cells show a ~37 kDa OTX2 band .
Validation: Recombinant OTX1 serves as a negative control for specificity .
Specificity: MA5-15854 detects a 32 kDa band in human samples, aligning with OTX2’s predicted molecular weight .
Species Reactivity: AF1979 cross-reacts with chicken and zebrafish in IHC but requires validation .
Limitations: Some antibodies (e.g., ab114138) lack validation in flow cytometry or immunoprecipitation .
What is Otx2 and why is it significant in developmental biology research?
Otx2 (orthodenticle homeobox 2) is a 289 amino acid homeodomain-containing transcription factor belonging to the bicoid subfamily. It plays critical roles in brain and sensory organ development during embryogenesis . The human Otx2 protein (accession # P32243) exists in multiple isoforms, with isoform b differing from isoform a by an eight amino acid insertion between positions P32 and A33 .
Researchers study Otx2 because of its essential functions in:
Neural tissue development and patterning
Eye and retinal formation
Brain regionalization, particularly in forebrain and midbrain
Embryonic stem cell differentiation pathways
What laboratory techniques can effectively utilize Otx2 antibodies?
Otx2 antibodies have been validated for multiple research applications:
For optimizing dilutions, researchers should perform titration experiments with their specific samples, as optimal concentrations vary by application and tissue type .
How should researchers select the appropriate Otx2 antibody for specific experimental needs?
Consider these critical parameters when selecting an Otx2 antibody:
Host species: Choose between rabbit polyclonal, goat polyclonal, or mouse monoclonal options based on compatibility with other reagents in multi-color experiments
Validated applications: Verify the antibody has been tested for your specific application (WB, IHC, Flow, etc.)
Species reactivity: Confirm cross-reactivity with your experimental model (human, mouse, rat, zebrafish, etc.)
Format: Standard vs. conjugated formats (e.g., Alexa Fluor® 488) for direct detection
Epitope location: Consider whether the antibody targets regions that may be affected by post-translational modifications
Always review validation data including Western blot images, immunofluorescence patterns, and flow cytometry profiles before selection .
What are the characteristic expression patterns of Otx2 during embryonic development?
Otx2 exhibits distinct spatiotemporal expression during embryogenesis:
Neural development: Prominently expressed in developing nervous system structures as demonstrated in mouse embryos at 14 days post-conception
Retinal development: Critical for optic vesicle formation, as shown in fish models where Otx2 co-localizes with neural markers like Sox2 and Rx2
Pluripotent cell differentiation: Expressed during neural differentiation from pluripotent stem cells
Immunohistochemical detection typically reveals nuclear localization, consistent with Otx2's function as a transcription factor .
What optimization strategies enable successful Otx2 antibody staining in challenging tissue samples?
For difficult-to-stain samples, consider these optimization approaches:
Antigen retrieval: For paraffin sections, heat-induced epitope retrieval using basic buffers significantly improves detection
Signal amplification: For low-abundance detection, employ polymer-based detection systems (e.g., Anti-Goat IgG VisUCyte™ HRP Polymer Antibody)
Fixation parameters: Adjust fixation time and conditions based on tissue type; immersion fixation works well for cultured cells and thin tissue sections
Alternative detection systems: Consider fluorophore-conjugated secondary antibodies (e.g., NorthernLights™ 557-conjugated Anti-Goat IgG) for improved signal-to-noise ratio
Permeabilization optimization: Test different detergent concentrations and incubation times to balance accessibility with structural preservation
Document all optimization parameters systematically to establish reproducible protocols for your specific samples.
How can researchers address potential cross-reactivity concerns with Otx2 antibodies?
Address specificity concerns through these validation strategies:
Western blot validation: Confirm detection of a single band at the expected molecular weight (approximately 37-48 kDa for Otx2)
Knockout/knockdown controls: Where available, use genetic models with reduced Otx2 expression
Multiple antibody validation: Compare results using antibodies targeting different Otx2 epitopes
Isotype controls: For flow cytometry, include appropriate isotype control antibodies to establish specificity
Peptide blocking experiments: Pre-incubate antibody with immunizing peptide to demonstrate binding specificity
For flow cytometry applications specifically, compare staining profiles between test antibody and isotype control to evaluate non-specific binding .
What approaches help resolve discrepancies in Otx2 detection between different antibodies or techniques?
When encountering inconsistent results:
Consider epitope accessibility: Different fixation and sample preparation methods may differentially expose epitopes
Evaluate isoform specificity: Some antibodies may preferentially detect specific Otx2 isoforms (a vs. b)
Assess post-translational modifications: Phosphorylation at T18, S28, or Y31 may affect antibody binding
Compare detection sensitivity thresholds: Western blot, immunofluorescence, and flow cytometry have different detection limits
Resolution strategies include:
Correlation with functional readouts
Parallel analysis with multiple detection methods
Literature comparison of Otx2 detection patterns in similar experimental systems
What methodologies enable accurate quantification of Otx2 expression in heterogeneous cell populations?
For quantitative assessment:
Flow cytometry: Provides single-cell resolution using protocols with appropriate fixation (Flow Cytometry Fixation Buffer) and permeabilization (Flow Cytometry Permeabilization/Wash Buffer I)
Quantitative imaging: Digital image analysis of immunofluorescence with nuclear counterstaining (DAPI) to quantify Otx2-positive nuclei
Multi-parameter analysis: Combine Otx2 staining with lineage markers (e.g., Sox2, Rx2) to identify co-expression patterns
Cell sorting: Isolate Otx2-positive subpopulations for downstream molecular analysis
Example: NTera-2 human testicular embryonic carcinoma cells show robust Otx2 expression detectable by flow cytometry using Alexa Fluor® 488-conjugated Otx2 antibody .
What essential controls should researchers include in Otx2 immunostaining experiments?
Comprehensive control strategy includes:
Positive tissue/cell controls: Include samples with known Otx2 expression (e.g., NTera-2 human testicular embryonic carcinoma or IMR-32 human neuroblastoma cell lines)
Negative controls: Include tissues where Otx2 expression is absent or developmentally regulated
Secondary antibody-only controls: Omit primary antibody to assess non-specific binding
Isotype controls: For flow cytometry applications, include isotype-matched non-specific antibodies
Specificity controls: When possible, include genetic models with altered Otx2 expression
For flow cytometry specifically, comparison between target antibody (e.g., Mouse Anti-Human Otx2 Alexa Fluor® 488-conjugated Monoclonal Antibody) and isotype control (e.g., IC0041G) is essential for accurate population gating .
How can researchers effectively perform multi-color immunostaining involving Otx2 antibodies?
For successful co-staining experiments:
Primary antibody compatibility: Select antibodies raised in different host species to prevent cross-reactivity
Fluorophore selection: Choose spectrally distinct fluorophores to enable clear signal separation
Sequential staining protocols: Consider sequential rather than simultaneous incubation for challenging combinations
Direct conjugates: Utilize directly labeled antibodies (e.g., Alexa Fluor® 488-conjugated Otx2 antibody) to simplify protocols
Nuclear counterstaining: Include DAPI to visualize nuclear localization of Otx2
Successful examples include co-staining of Otx2 with Sox2 and Rx2 in neural development studies, which enables analysis of transcription factor networks during differentiation .
What fixation and antigen retrieval protocols optimize Otx2 detection in different sample types?
Sample-specific recommendations:
Critical notes:
For paraffin sections, heat-induced epitope retrieval using Antigen Retrieval Reagent-Basic significantly improves detection sensitivity
Embryonic tissues may require shorter fixation times to preserve antigenicity
Storage considerations: Most Otx2 antibodies should be stored at 2-8°C and protected from light; freezing should be avoided for conjugated formats
What strategies validate Otx2 antibody specificity for specific experimental systems?
Comprehensive validation approach:
Western blot analysis: Confirm detection of appropriate molecular weight bands (37 kDa in IMR-32 cells under reducing conditions; 48 kDa in Simple Western system)
Expression pattern analysis: Verify detection in tissues with established Otx2 expression patterns (e.g., developing nervous system in embryos)
Multiple antibody comparison: Test different antibodies targeting distinct epitopes of Otx2
Functional correlation: Correlate antibody staining with known developmental or functional roles of Otx2
Cross-species validation: If working with non-human models, verify expected evolutionary conservation of detection patterns
Document all validation experiments systematically, including specific antibody catalog numbers, dilutions, and experimental conditions to ensure reproducibility.